Aesica and EmulTech have entered an agreement for the commercial development of ET4ME, a sterile emulsion technology for product formulation. ET4ME is a micro-encapsulation technology developed by the EmulTech group that uses a specialized microfluidic process to create a measurable microparticulate suspension where particle size is uniform and reproducible. The technology can be used for APIs from small molecules to complex biomolecules, with high levels of batch consistency and reproducibility...